Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Peptidases released by necrotic cells control CD8+ T cell cross-priming.

Gamrekelashvili J, Kapanadze T, Han M, Wissing J, Ma C, Jaensch L, Manns MP, Armstrong T, Jaffee E, White AO, Citrin DE, Korangy F, Greten TF.

J Clin Invest. 2013 Nov;123(11):4755-68.

2.

Mechanism of dichotomy between CD8+ responses elicited by apoptotic and necrotic cells.

Buckwalter MR, Srivastava PK.

Cancer Immun. 2013;13:2. Epub 2013 Jan 15.

3.

A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.

Hunzeker JT, Elftman MD, Mellinger JC, Princiotta MF, Bonneau RH, Truckenmiller ME, Norbury CC.

J Immunol. 2011 Jan 1;186(1):183-94. doi: 10.4049/jimmunol.1001737. Epub 2010 Nov 22.

4.

The dendritic cell receptor DNGR-1 controls endocytic handling of necrotic cell antigens to favor cross-priming of CTLs in virus-infected mice.

Zelenay S, Keller AM, Whitney PG, Schraml BU, Deddouche S, Rogers NC, Schulz O, Sancho D, Reis e Sousa C.

J Clin Invest. 2012 May;122(5):1615-27. doi: 10.1172/JCI60644. Epub 2012 Apr 16.

5.

Primary sterile necrotic cells fail to cross-prime CD8(+) T cells.

Gamrekelashvili J, Ormandy LA, Heimesaat MM, Kirschning CJ, Manns MP, Korangy F, Greten TF.

Oncoimmunology. 2012 Oct 1;1(7):1017-1026.

6.

Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.

Busche A, Jirmo AC, Welten SP, Zischke J, Noack J, Constabel H, Gatzke AK, Keyser KA, Arens R, Behrens GM, Messerle M.

J Immunol. 2013 Mar 15;190(6):2767-77. doi: 10.4049/jimmunol.1200966. Epub 2013 Feb 6.

7.

Exploiting cross-priming to generate protective CD8 T-cell immunity rapidly.

Pham NL, Pewe LL, Fleenor CJ, Langlois RA, Legge KL, Badovinac VP, Harty JT.

Proc Natl Acad Sci U S A. 2010 Jul 6;107(27):12198-203. doi: 10.1073/pnas.1004661107. Epub 2010 Jun 21.

8.

Identification of a dendritic cell receptor that couples sensing of necrosis to immunity.

Sancho D, Joffre OP, Keller AM, Rogers NC, Martínez D, Hernanz-Falcón P, Rosewell I, Reis e Sousa C.

Nature. 2009 Apr 16;458(7240):899-903. doi: 10.1038/nature07750.

9.

ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.

Duewell P, Kisser U, Heckelsmiller K, Hoves S, Stoitzner P, Koernig S, Morelli AB, Clausen BE, Dauer M, Eigler A, Anz D, Bourquin C, Maraskovsky E, Endres S, Schnurr M.

J Immunol. 2011 Jul 1;187(1):55-63. doi: 10.4049/jimmunol.1004114. Epub 2011 May 25.

10.

Dendritic cell cross-priming is essential for immune responses to Listeria monocytogenes.

Reinicke AT, Omilusik KD, Basha G, Jefferies WA.

PLoS One. 2009 Oct 6;4(10):e7210. doi: 10.1371/journal.pone.0007210.

11.

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.

Galea-Lauri J, Wells JW, Darling D, Harrison P, Farzaneh F.

Cancer Immunol Immunother. 2004 Nov;53(11):963-77. Epub 2004 May 14.

PMID:
15146294
12.

Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity.

Heit A, Gebhardt F, Lahl K, Neuenhahn M, Schmitz F, Anderl F, Wagner H, Sparwasser T, Busch DH, Kastenmüller K.

Eur J Immunol. 2008 Jun;38(6):1585-97. doi: 10.1002/eji.200737966.

13.

Autophagy within the antigen donor cell facilitates efficient antigen cross-priming of virus-specific CD8+ T cells.

Uhl M, Kepp O, Jusforgues-Saklani H, Vicencio JM, Kroemer G, Albert ML.

Cell Death Differ. 2009 Jul;16(7):991-1005. doi: 10.1038/cdd.2009.8. Epub 2009 Feb 20.

14.

TRAIL/DR5 plays a critical role in NK cell-mediated negative regulation of dendritic cell cross-priming of T cells.

Iyori M, Zhang T, Pantel H, Gagne BA, Sentman CL.

J Immunol. 2011 Sep 15;187(6):3087-95. doi: 10.4049/jimmunol.1003879. Epub 2011 Aug 10.

15.

Analysis of the role of tripeptidyl peptidase II in MHC class I antigen presentation in vivo.

Kawahara M, York IA, Hearn A, Farfan D, Rock KL.

J Immunol. 2009 Nov 15;183(10):6069-77. doi: 10.4049/jimmunol.0803564. Epub 2009 Oct 19.

16.

Influenza A infection enhances cross-priming of CD8+ T cells to cell-associated antigens in a TLR7- and type I IFN-dependent fashion.

Wei J, Waithman J, Lata R, Mifsud NA, Cebon J, Kay T, Smyth MJ, Sadler AJ, Chen W.

J Immunol. 2010 Nov 15;185(10):6013-22. doi: 10.4049/jimmunol.1002129. Epub 2010 Oct 18.

17.

Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.

Wang H, Yu X, Guo C, Zuo D, Fisher PB, Subjeck JR, Wang XY.

J Immunol. 2013 Dec 15;191(12):6010-21. doi: 10.4049/jimmunol.1302312. Epub 2013 Nov 11.

18.

ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.

Schnurr M, Orban M, Robson NC, Shin A, Braley H, Airey D, Cebon J, Maraskovsky E, Endres S.

J Immunol. 2009 Feb 1;182(3):1253-9. Erratum in: J Immunol. 2009 Apr 15;182(8):5152.

19.

Role of dipeptidyl peptidase IV (DP IV)-like enzymes in T lymphocyte activation: investigations in DP IV/CD26-knockout mice.

Reinhold D, Goihl A, Wrenger S, Reinhold A, Kühlmann UC, Faust J, Neubert K, Thielitz A, Brocke S, Täger M, Ansorge S, Bank U.

Clin Chem Lab Med. 2009;47(3):268-74.

PMID:
19676138
20.

Analysis of direct and cross-presentation of antigens in TPPII knockout mice.

Firat E, Huai J, Saveanu L, Gaedicke S, Aichele P, Eichmann K, van Endert P, Niedermann G.

J Immunol. 2007 Dec 15;179(12):8137-45.

Supplemental Content

Support Center